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The objectives of this study were to evaluate the accuracy of endoscopic ultrasonography (EUS) in 
local and regional staging of early gastric cancer,  to analyze the factors inﬂuencing the accuracy of 
EUS,  and to reveal the usefulness and problems of EUS in pre-treatment staging of gastric cancer.  We 
examined 105 lesions in 104 patients with histologically conﬁrmed gastric cancer and retrospectively 
evaluated them with EUS.  The diagnostic accuracy,  sensitivity,  and speciﬁcity of EUS were deter-
mined by comparing the pre-treatment EUS with the postoperative histopathological ﬁndings.  The 
overall diagnostic accuracy of EUS for the depth of cancer invasion was 86ｵ.  The overall sensitivity 
and speciﬁcity were 60ｵ and 96ｵ,  respectively.  The accuracy signiﬁcantly declined in lesions located 
in the upper-third of the stomach (70ｵ).  Type 0-I lesions tended to be over-staged (12ｵ),  and the 
upper-third lesions tended to be under-staged (23ｵ).  The accuracy signiﬁcantly declined in diﬀerenti-
ated adenocarcinoma with massive submucosal invasion (56.5ｵ).  EUS is useful for evaluating the depth 
of gastric cancer invasion which determines the feasibility of endoscopic treatment.  However,  it is 
noteworthy that the diagnostic accuracy of the invasion depth diminished for lesions in the upper third 
of the stomach.
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arly gastric cancer (EGC) is deﬁned as gastric 
cancer that is conﬁned to the mucosal or submu-
cosal layers,  regardless of the presence or absence of 
lymph node metastasis [1].  Endoscopic treatment 
such as endoscopic mucosal resection and endoscopic 
submucosal dissection (ESD) is currently accepted in 
Japan as a standard strategy for a subgroup of 
patients with EGC without any risk of lymph node 
metastasis [2-5] because it is minimally invasive,  
safe,  and convenient.  In addition,  a large-scale study 
has revealed that its long-term eﬃcacy is excellent 
[6].  The Japanese Gastric Cancer Association 
(JGCA) has established the accepted indications for 
endoscopic resection of early gastric carcinoma as 
follows: (i) diﬀerentiated-type adenocarcinoma; (ii) 
tumor less than 20mm in diameter; and (iii) tumor 
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invasion limited to the mucosa without any ulcerous 
changes and no expected lymph node metastasis [7].  
Gotoda et al.  have reported that diﬀerentiated adeno-
carcinoma lesions 30mm in diameter or larger were 
entirely free of nodal metastasis if they showed a lack 
of lymphatic-vascular capillary involvement and if the 
submucosal penetration was 500µm or less [3].  
Hirasawa et al.  have reported that intramucosal undif-
ferentiated adenocarcinoma 20mm in diameter or 
smaller without lymphatic-vascular capillary involve-
ment or ulcerous ﬁndings present a negligible risk of 
lymph node metastasis [8].  Therefore,  the extended 
indications for endoscopic resection have been pro-
posed as follows: (i) intramucosal cancer,  diﬀerenti-
ated-type adenocarcinoma,  no lymphatic-vascular 
invasion,  with no ulceration and irrespective of the 
tumor size; (ii) intramucosal cancer,  diﬀerentiated-
type adenocarcinoma,  no lymphatic-vascular invasion,  
irrespective of ulceration and less than 3cm in 
size; (iii) minute submucosal cancer (ｦ500µm pene-
tration into the submucosa),  diﬀerentiated-type adeno-
carcinoma,  no lymphatic-vascular invasion,  with no 
ulceration and less than 3cm in size; and (iv) intramu-
cosal cancer,  undiﬀerentiated-type carcinoma,  no 
lymphatic-vascular invasion,  with no ulceration and 
less than 2cm in size [7].  With the increasingly 
expanded indications of endoscopic resection for EGC,  
it has become more important in the pre-treatment 
planning to accurately determine the depth of invasion.
　 Endoscopic ultrasonography (EUS) is considered 
the best diagnostic modality for local and regional 
staging,  and is commonly used for diﬀerentiating 
mucosal lesions from submucosal lesions for endo-
scopic resection [9,  10].  Nonetheless,  previous 
reports have suggested that the accuracy of EUS is 
inﬂuenced by several factors: endoscopic ﬁndings,  the 
location of the lesion,  the stage of the gastric cancer,  
tumor size,  and study design [9,  11-13].  
　 The objectives of this study were to evaluate the 
accuracy of EUS in local and regional staging of early 
gastric cancer,  to analyze clinicopathological factors 
inﬂuencing the diagnostic accuracy of EUS in predict-
ing the depth of tumor invasion,  and to reveal the 
usefulness and problems of EUS in pre-treatment 
staging of gastric cancer.
Materials and Methods
　 Patients. We performed EUS before treat-
ment for gastric cancer when the depth of tumor 
invasion was diﬃcult to assess by conventional endos-
copy.  Between September 2003 and October 2009,  
105 lesions in 104 patients (75 men and 29 women) 
with gastric cancer diagnosed by conventional endo-
scopic examination and conﬁrmed with a biopsy speci-
men,  underwent EUS examination to determine the 
depth of tumor invasion prior to endoscopic resection 
or surgery at our institution.  Of these 105 lesions 
investigated in the present study,  78 underwent ESD 
and 27 underwent surgery.  EUS was performed for 
these lesions due to diﬃculties in diagnosing the depth 
of the tumor invasions.
　 EUS equipment and examination procedures.
The instrument used for the EUS examinations was a 
miniature sonoprobe system (UM-3R,  with an ultra-
sound frequency of 20MHz,  Olympus,  Tokyo,  Japan).  
Prior to EUS,  examination was performed by conven-
tional endoscopy with biopsy to conﬁrm gastric cancer.  
After pre-medication with local pharyngeal anesthesia 
and diazepam (2.5-5mg intravenously) or ﬂunitraze-
pam (0.5-1mg intravenously),  if needed,  the patients 
were examined in the left lateral decubitus position.  
Under direct vision,  the echoendoscope was advanced 
beyond the tumor.  Acoustic coupling with the gastro-
intestinal (GI) wall was obtained by instilling 200-
500ml of deaerated water into the gastric lumen.  
EUS imaging was performed by the same group of 
endosonographers under the supervision of the leading 
endoscopist at out institution (R. T.,  H. O,  or Y. K. ).  
We obtained written informed consent from all the 
patients before the endoscopic procedures.
　 Deﬁnition and identiﬁcation of cancer inva-
sion depth. On endoscopy,  submucosal or deeper 
invasion by the lesions was assessed by the presence 
of an uneven nodular surface without ﬂexibility,  a 
marked depression in the elevated lesion,  fold conver-
gence with bulging,  or consistent submucosal elevation 
around the lesion [14].
　 On EUS,  the gastric wall was assessed based on 
the standard ﬁve-layer sonographic structure [9,  15].  
On the EUS image,  the ﬁrst hyperechoic and second 
hypoechoic layers (layers 1 and 2) represent the 
mucosa (M),  the third hyperechoic layer (layer 3) 
represents the submucosa (SM),  the fourth 
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hypoechoic layer (layer 4) corresponds to the muscu-
laris propria (MP),  and the ﬁfth hyperechoic layer 
(layer 5) reﬂects the subserosa and serosa (SS).  
Cancer depth was evaluated as M if the hypoechoic 
mass disrupted the sonographic layers 1 to 2; and as 
SM or deeper if it disrupted layers 1 to 3 or deeper.
　 Data analysis. Detailed information regarding 
the endoscopic images and the results of the histo-
pathological examination were obtained from the 
medical records.
　 The tumor locations were categorized by the longi-
tudinal axis of the stomach,  divided into three sec-
tions (upper third containing the fundus,  cardia,  and 
upper body; middle third containing the middle body,  
lower body,  and angle; and lower third containing the 
antrum and pylorus).  The endoscopic ﬁndings related 
to the tumor were categorized according to the JGCA 
classiﬁcation [2].  The macroscopic type was deﬁned 
as protruded type (0-I and 0-I＋IIa),  elevated/ﬂat 
type (0-IIa,  0-IIb,  0-IIa＋IIb),  depressed type (0-IIc,  
0-III,  0-IIIc＋III),  or combined type (0-IIa＋IIc or 
III).
　 All resected specimens were sectioned into 2- to 
5-mm slices and evaluated histopathologically based 
on the JGCA classiﬁcation [2].  Undiﬀerentiated 
adenocarcinoma in this classiﬁcation lacks gland for-
mation and includes poorly diﬀerentiated adenocarci-
noma,  signet-ring cell carcinoma,  and mucinous ade-
nocarcinoma as in the World Health Organization 
classiﬁcation [16].
　 The depth of submucosal invasion was sub-classi-
ﬁed histologically into one of 2 grades: penetration 
into the submucosal layer less than 500µm from the 
muscularis mucosa (SM1) or penetration of 500µm or 
deeper (SM2) [2].  The tumor size and pathologic 
ulceration were determined histopathologically,  and 
the size of the resected specimen was recorded as the 
largest measured diameter.
　 We analyzed the diagnostic accuracy of EUS in 
determining whether the lesions met the expanded-
indication criteria for ESD in the patients with EGC,  
and investigated the clinicopathological factors aﬀect-
ing the diagnostic accuracy of EUS in measuring the 
invasion depth of EGC.  In this study,  M and SM1 
were combined into the same category in calculating 
the accuracy rate because EUS has diﬃculty in distin-
guishing M from SM1 [17].
　 Statistical analysis. The accuracy,  sensitivity,  
and speciﬁcity of EUS in detecting tumor invasion 
beyond SM1 were calculated manually.  The accuracy 
of EUS in relation to the clinicopathological features 
was assessed using the chi-square test and Fisherʼs 
exact test.  The level of signiﬁcance was set at a p 
value less than 0.05.  Statistical analyses were per-
formed with StatView software (SAS Institute,  Cary,  
NC,  USA).
Results
　 Demographic, endoscopic, and histological 
characteristics. Table 1 shows the baseline char-
acteristics of the study population and the clinico-
pathological features of the enrolled patientsʼ lesions.  
The median age of the patients was 70 years 
(range: 52-91 years),  and the male: female ratio was 
2.59：1 (75：29).  Thirty lesions (29ｵ) were located 
in the upper third of the stomach,  36 (34ｵ) in the 
middle third,  and 39 (37ｵ) in the lower third.  The 
median tumor diameter was 20mm (range: 5-60mm).  
There were 8 lesions (8ｵ) with type 0-I tumors,  33 
(31ｵ) with type 0-IIa or IIa＋IIc (mainly superﬁcial 
elevated type),  and 64 (61ｵ) with type 0-IIc or 0-IIc
＋IIa (mainly superﬁcial depressed type). The patho-
logical depth was M-SM1 for 77 lesions (73ｵ),  SM2 
for 25 (24ｵ),  and MP or deeper for 3 (3ｵ).  The 
histological examination showed that 96 lesions 
(91.4ｵ) were diﬀerentiated adenocarcinoma and the 
others were undifferentiated adenocarcinoma.  
Seventeen lesions (16ｵ) had concomitant ulcerous 
ﬁndings histologically.
　 Diagnostic accuracy of EUS in assessing the 
tumor invasion depth. The overall accuracy of 
EUS in predicting the depth of tumor invasion was 
86ｵ.  As shown in Table 2,  the accuracy tended to 
decline in lesions located in the upper third of the 
stomach (70ｵ),  lesions with a diameter between 11 
and 20mm (80ｵ),  and those of the mainly superﬁcial 
elevated type (82ｵ).  However,  there were signiﬁcant 
diﬀerences in the accuracy among each category only 
in the upper third lesions (p＝0.01).  On the whole,  we 
tended to under-stage by EUS more frequently than 
over-stage (11ｵ vs.  3ｵ).  On the contrary,  we 
tended to over-stage more frequently than under-stage 
in the lower third lesions (8ｵ vs.  2ｵ),  O-I lesions 
(12ｵ vs.  0ｵ),  and lesions with ulcers (6ｵ vs.  0ｵ).  
However,  there were signiﬁcant diﬀerences in over-
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staging among each category only in 0-I lesions (p＝
0.05).  There were no signiﬁcant diﬀerences in accu-
racy,  over-staging,  or under-staging between diﬀeren-
tiated and undiﬀerentiated adenocarcinoma.  Similarly,  
there were no signiﬁcant diﬀerences in more detailed 
histological assessments,  namely well-,  moderately,  
papillary,  poorly diﬀerentiated adenocarcinoma and 
signet ring cell.
　 Table 3 shows the sensitivity and speciﬁcity of 
EUS in detecting tumor invasion beyond SM1.  
Overall,  EUS showed both a low sensitivity (60ｵ) 
and a high speciﬁcity (96ｵ).  Two parameters had a 
high sensitivity,  namely,  a macroscopic type 0-I and a 
lesion with ulcer.
　 The accuracy of EUS was reevaluated according to 
the accepted and extended indications for endoscopic 
resection (Table 4).  The levels of accuracy of EUS 
for the lesions with accepted indications and with 
extended indications were 94.1ｵ (32 of 34 lesions) 
and 95.4ｵ (42 of 44 lesions),  respectively (Table 
4-b).  For the lesions beyond the extended indications 
for ESD,  the accuracy of EUS was 59.3ｵ (16 of 27 
lesions) (Table 4-b).  Of the 11 lesions that were 
incorrectly diagnosed,  7 were located in the upper 
third of the stomach.  (Data not shown. )
Discussion
　 Currently,  EUS is the most reliable diagnostic 
modality used to predict the depth of gastric cancer 
with high accuracy [18].  The accuracy of EUS for 
local and regional staging of gastric cancer ranges 
from 65ｵ to 92ｵ [10].  In the present study,  we 
retrospectively investigated the accuracy of EUS in 
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Table 1　 The clinical background of our study subjects
Patientsʼ characteristics (n＝104)
Age (years)　　　Median (range) 70 (52-91)
Gender　　　　Male / Female (％) 75 (72％) / 29 (28％)
Lesion characteristics　　(n＝105) 　
Location　　　　U / M / L 30 (29％) / 36 (34％) / 39 (37％)





Macroscopic type  
　　　0-I 8 (8％)
　　　0-IIa,  0-IIa＋ IIc 33 (31％)
　　　0-IIc,  0-IIc＋ IIa 64 (61％)
Pathologic depth 
　　　M-SM1 (＜500µm) 77 (73％)
　　　SM2 25 (24％)
　　　MP or deeper 3 (3％)
Histology
　　　Diﬀerentiated 97 (92％)
　　　　　tub1 / tub2 /pap 73 (69％) / 22 (21％) /2 (2％)
　　　Undiﬀerentiated 8 (8％)
　　　　　por / sig 5 (5％) / 3(3 ％)
Ulcerous (Ul) ﬁndings histologically
　　　Ul＋ / Ul－ 17 (16％) / 88 (84％)
U,  upper their; M,  middle third; L,  lower third; 0-I,  protruding type; 0-IIa,  superﬁcial elevated type; 0-IIc,  superﬁcial depressed type; M,  
mucosal; SM1,  submucosal layer less than 500µm from the muscularis mucosa; SM2,  submucosal layer penetration of 500µm or 
deeper; MP,  muscularis propria; Ul (－),  lesions without ulcerous ﬁndings; Ul (＋),  lesions with ulcerous ﬁndings; tub1,  well-diﬀerenti-
ated tubular adenocarcinoma; tub2,  moderately diﬀerentiated tubular adenocarcinoma; pap,  papillary adenocarcinoma; por,  poorly dif-
ferentiated adenocarcinoma; sig,  signet ring cell carcinoma.
EGC by using a 20-MHz catheter probe.  We per-
formed EUS only for diﬃcult cases such as those with 
suspected submucosal invasion or concomitant ulcerous 
changes or relatively large lesions.  However,  the 
accuracy of the EUS in assessing the tumor invasion 
depth was 86ｵ,  which is compatible with previous 
studies [10].  One of the reasons for its ﬁne accuracy 
is that M and SM1 are combined into one category 
when calculating the accuracy rate in considering the 
resolution of EUS [19] and the criteria for indica-
tions for ESD [3].  When calculated for distinguish-
ing M from SM1,  the accuracy rate of EUS in pre-
dicting the tumor invasion depth was 70ｵ in the 
present study (data not shown).
　 To evaluate the invasion depth of EGC,  clinico-
pathological factors,  including location,  macroscopic 
type,  size,  histology,  and ulcerative change,  have 
been established as important factors that inﬂuence 
the local and regional staging accuracy of EUS [11,  
20,  21].  With regard to the lesion location in this 
study,  the accuracy signiﬁcantly declined in the upper 
third lesions as compared with the other locations 
(Table 2),  which is consistent with previous study 
results [11].  In this location,  the staging rate was 
signiﬁcantly higher than that in the other locations.  
Lesions in the upper third of the stomach,  where 
adequate ﬁlling with deaerated water is not possible,  
are diﬃcult to access by EUS [14].  In the upper 
third of the stomach,  the submucosal layer is rela-
tively thin and tends to have ﬁbrosis and many vessels 
[22],  which may make the signs of submucosal inva-
sion diﬃcult to detect,  thus leading to under-staging.
　 In the present study,  we calculated not only the 
accuracy but also the sensitivity and speciﬁcity for the 
detection of SM2 or deeper invasion to categorically 
evaluate the usefulness of EUS (Table 3).  Overall,  
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Table 2　 Summary of the accuracy,  over-staging,  and under-staging of local and regional staging





Overall 105 86％ 3％ 11％
Location
Upper third 30 70％ (0.02)＊ 7％ (0.62) 23％ (0.03)＊
Middle third 36 89％ (0.40) 0％ (0.16) 11％ (0.99)
Lower third 39 90％ (0.27) 8％ (0.35) 2％ (0.03)＊
Tumor diameter (histologically) 
ｦ10mm 23 91％ (0.35) 0％ (0.58) 9％ (0.99)
11-20mm 35 80％ (0.26) 9％ (0.33) 11％ (0.52)
ｧ21mm 37 90％ (0.79) 2％ (0.99) 11％ (0.99)
Macroscopic type
0-I 8 88％ (0.61) 12％ (0.05)＊ 0％ (0.59)
0-IIa,  0-IIa＋ IIc 33 82％ (0.77) 6％ (0.64) 12％ (0.99)
0-IIc,  0-IIc＋ IIa 64 86％ (0.58) 2％ (0.07) 12％ (0.76)
Histology
Diﬀerentiated 97 86％ (0.99) 3％ (0.99) 11％ (0.99)
tub1 73 85％ (0.77) 7％ (0.31) 8％ (0.17)
tub2 22 82％ (0.75) 0％ (0.58) 18％ (0.27)
pap 2 50％ (0.29) 0％ (0.99) 50％ (0.21)
Undiﬀerentiated 8 87.5％ (0.99) 0％ (0.99) 12.5％ (0.99)
por 5 80％ (0.99) 0％ (0.99) 12.5％ (0.99)
sig 3 100％ (0.99) 0％ (0.99) 25％ (0.46)
Ulcerous (Ul) ﬁndings histologically
Ul＋ 17 94％ (0.29) 6％ (0.99) 0％ (0.20)
　 Ul－ 88 84％ (0.29) 2％ (0.99) 14％ (0.20)
P values are calculated by the Fisherʼs exact test.  O-I,  protruding type; O-IIa,  superﬁcial elevated type; O-IIc,  superﬁcial depressed type;
Ul－ ,  lesions without ulcerous ﬁndings; Ul＋ ,  lesions with ulcerous ﬁndings; tub1,  well-diﬀerentiated tubular adenocarcinoma; tub2,  
moderately diﬀerentiated tubular adenocarcinoma; pap,  papillary adenocarcinoma; por,  poorly diﬀerentiated adenocarcinoma; sig,  signet 
ring cell carcinoma.　＊p≦0.05
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Table 4　 Accuracy of EUS for predicting cancer invasion according to the accepted and extended indications for endoscopic resection
4-a
Histology
Mucosal cancer Submucosal cancer
Ulcer (－) Ulcer (＋) SM1 ｧ SM2
ｦ 20mm ＞20mm ｦ 30mm ＞30mm ｦ 30mm ＞30mm any size
Diﬀerentiated 32/34 20/20 7/8 0 10/10 1/1 13/23
94.1％ 100％ 87.5％ - 100.0％ 100％ 56.5％＊
Undiﬀerentiated 5/6 1/1 0 0 1/1 0/1
83.3％ 100％ 100％ 0％
4-b
n Accuracy Over-staging Under-staging
Accepted indications for endoscopic resection 34 94.1％ 5.9％ 0％
Extended indication for endoscopic submucosal 
dissection (ESD) 44 95.4％ 2.3％ 2.3％
Beyond the extended indication for ESD 27 59.3％＊ 0％ 40.7％
 ＊p＜0.0001
M,  mucosal; SM1, submucosal layer less than 500µm from the muscularis mucosa; SM2,  submucosal layer penetration of 500µm or 
deeper.
Accepted indications for endoscopic resection; Extended indication for endoscopic submucosal dissection (ESD);
Beyond the extended indication for ESD.
Table 3　 Summary of the accuracy,  sensitivity,  and speciﬁcity of EUS for diagnosing SM2 or deeper cancer
Lesion characteristics n Accuracy (％) Sensitivity (％) Speciﬁcity (％)
Overall 105 86 60 96
Location
Upper third 30 70 30 90
Middle third 36 89 64 100
Lower third 39 90 80 97
Tumor diameter (histologically) 
ｦ10mm 23 91 50 100
11-20mm 35 80 50 89
ｧ21mm 37 90 67 97
Macroscopic type
0-I 8 88 100 86
0-IIa, 0-IIa＋ IIc 33 82 50 92
0-IIc, 0-IIc＋ IIa 64 86 58 98
Histology
Diﬀerentiated 97 86 60 96
Undiﬀerentiated 8 87.5 75 100
Ulcerous (Ul) ﬁndings histologically
Ul＋ 17 94 100 89
　 Ul－ 88 84 30 90
O-I,  protruding type; O-IIa,  superﬁcial elevated type; O-IIc,  superﬁcial depressed type; Ul－ ,  lesions without ulcerous ﬁndings; Ul＋ ,  
lesions with ulcerous ﬁndings.
EUS showed both a low sensitivity (60ｵ) and a high 
speciﬁcity (96ｵ).  This statistically means that EUS 
is in general useful to conﬁrm the diagnosis of SM2 or 
deeper invasion,  but not to rule out SM2 or deeper 
invasion,  namely to conﬁrm the diagnosis of M or 
SM1 tumor,  and it is inadequate for the screening of 
SM2 or deeper tumors.
　 In our study,  type 0-I lesions and UL＋lesions had 
relatively good accuracy,  high speciﬁcity (100ｵ),  and 
relatively good sensitivity.  It is generally reported 
that these lesions often make the diagnosis of invasion 
depth of gastric cancer diﬃcult because 0-I lesions are 
sometimes too thick to visualize the submucosal layer 
using a 20-MHz probe,  and ulcerous lesions com-
monly have ﬁbrosis and inﬂammatory cells that might 
be misinterpreted as tumor invasion [21].  In the 
present study,  EUS was performed just after conven-
tional endoscopic examination,  which may inﬂuence 
the diagnosis by EUS.  However,  type 0-I lesions and 
UL＋lesions are considered to be highly indicative of 
sm invasion in conventional endoscopic diagnosis [14,  
23].  It is therefore diﬃcult to exclude the possibility 
that these lesions were diagnosed as greater than SM2 
due to the endoscopic ﬁndings when the EUS diagnosis 
of depth of invasion was diﬃcult.  This result may 
explain why these lesions had good results and were 
not under-staged in our study (Table 2).
　 Concerning the histological ﬁndings,  there were no 
statistical diﬀerences between the diﬀerentiated and 
undiﬀerentiated types in the present study.  This 
result cannot be adequately relied upon because we had 
only a few cases of the undiﬀerentiated type.
　 The diagnostic accuracy of EUS was signiﬁcantly 
lower in the cases requiring surgical intervention as 
compared to those indicated for endoscopic resection 
(Table 4).  These results are consistent with the study 
of Kim et al.  [24] In the present study,  most of the 
misdiagnosed lesions (7 of 11 cases) were located in 
the upper third of the stomach.  As described earlier,  
we believe that the presence of thin and ﬁbrotic sub-
mucosal layers in this region [22] contributed to the 
decreased diagnostic accuracy.
　 As already stated,  there were several method-
ological limitations to the present study.  First,  this 
was a retrospective study and,  for the cases that were 
diﬃcult to diagnosis with EUS,  it is possible that the 
diagnosis with conventional endoscopy performed 
immediately before EUS aﬀected the EUS diagnostic 
results.  Second,  the number of cases investigated in 
the present study was relatively small.  Further pro-
spective studies that include larger numbers of 
patients with EGC are required to obtain more accu-
rate results.
　 In conclusion,  EUS is useful to conﬁrm whether 
the depth of early gastric cancer is included in the 
accepted or extended indications of ESD.  
Nonetheless,  the lesions in the upper third of the 
stomach were associated with an incorrect diagnosis.  
It is important to perform EUS to compensate for the 
diagnosis by conventional endoscopy when considering 
the clinicopathological factors of the tumor.
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